Agilent Technologies (A) Opções

https://www.japantimes.co.jp/news/2025/04/28/world/politics/us-aid-ukraine-russian-hacks/
I know one way to make this much cheaper! Use Wave.

https://www.theregister.com/2025/04/28/who_me/
Are they joking about this now? Use Wave.

Thanks Silvr. Since CGON has dragged their feet or contested discovery on many issues, it looks like they may be trying to delay the trial by extending deadlines.

You played loto, you lost, your fault

Stop whining

https://investorshub.advfn.com/uimage/uploads/2019/9/30/azehuMouse_GNCP.jpg

Electromountain, Not difficult to understand at all. Many of us are all experiencing the same fate. You are not alone here. But it’s no use constantly looking backwards all the time. Get over it, “your paper losses’ could disappear faster than they happened. Try to look forward, Your probably stil

Ich auch

Might be worth buying if they would stop diluting it!

Everyone still waiting for anything from the great CEO.
The new angle from the pumpers...wait until the new May fins for FOXO. As if any of the info from FOXO has done anything positive for this ticker. But hey, pumper posts have the little Santa emogis. That proves something. 🤣ǹ

Imagine your BTC being traced back to hackers, you don't think it won't be confiscated?

WAKE UP!

I still think it would be worthwhile for biotech investors to do themselves to better understand the facts that do exist, instead of relying on raw ChatGPT nonsense..

I'm in. 

We all know how it works. The 0.04 cent propagandists sell there shares into a lqmt pop, and then try to convince all the newbies to sell there shares.

They call this the wash rinse and repeat when it’s just really deception, manipulation, and preying on inexperienced investors.

Recent Biotech Buyouts of Publicly Traded Companies

[Added MRK.DE-SWTX.]

Table entries are in descending order of buyout premium.
Reverse-mergers are listed at the bottom. [pre]
Acquired ‡Premium *Deal iHub
Company Buyer to Mark

MRK.DE acquires SWTX for $47/sh cash—a 17% premium to SWTX’s “unaffected” share price on 2/7/25:

https://www.businesswire.com/news/home/20250427077657/en/Merck-KGaA-Darmstadt-Germany-to-Acquire-US-Biopharma-Company-SpringWorks-Therapeutics-to-Accelerate-Sustainable-Growth-of-Healthcar

Unfortunately for you, your desire to get extremely wealthy off the back of this faux 'cancer treatment' is zero, as both the FDA & MHRA, are fully aware of this biotech's 20+ year criminally fraudulent, enterprise.

It's only morally corrupt parasites like you who think that they can

People are becoming disgruntled and angry because the former CEO of LWLG allegedly misled shareholders for years. This deception may have caused significant financial losses, as investors trusted the CEO's statements and strategies, only to discover that the company's performance or prospects were n

"Unholy mixing of QREE and FLCX" ?, I would call it incestuous.

🤔🫣w/$0.0001 AVERAGE COST (translate profit in writing) three hundred billion 💰️???

yes

That's nott thinking, that's hallucinating.

https://investorshub.advfn.com/uimage/uploads/2024/1/31/unbbpdelusion_kob[mdelusions-quotes-3.jpg
https://investorshub.advfn.com/uimage/uploads/2024/2/17/mqvyidelusions_77.jpg
https://investorshub.advfn.com/uimage/uploads/2025

d_stock
@d_stock07734
·
5h
According to the PR from last December, YA II PN, Ltd. can convert all the Note into shares once sp is above $0.315 and after all the Note was converted, $NWBO can let YA II PN, Ltd load shares up to $50m. Is my understanding right? Can some $NW

I agree Gary. But remember the NWBO vs the Seven Market Makers lawsuit was instigated by NWBO and as a basis for liability alleged harm by illegal actions. This is a civil suit that alleged criminal actions. NWBO can collect damages that is all. But all evedence collected, deposition testimony elici

Cell and Gene Therapy Sector Enters ‘Critical’ Period After Marks’ FDA Exit :
April 28, 2025

"This could be good news for the cell and gene therapy (CGT) space as many of these therapies—particularly those for rare indications—rely on surrogate endpoints that make them uniquely